Association of TNF, MBL, and VDR polymorphisms with leprosy phenotypes

Human Immunology

Volumn 71, Issue 10, 2010, Pages 992-998

  Sapkota, Bishwa R ^a   Macdonald, Murdo ^a   Berrington, William R ^b   Misch, E Ann ^b   Ranjit, Chaman ^a   Siddiqui, M Ruby ^c   Kaplan, Gilla ^c   Hawn, Thomas R ^b  

^a Anandaban Leprosy Hospital   (Nepal)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Genetic polymorphism; Mannose binding lectin; Mycobacterium leprae; TNF; Vitamin D receptor

Indexed keywords

MANNOSE BINDING LECTIN; TUMOR NECROSIS FACTOR; VITAMIN D RECEPTOR;

AGE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; ERYTHEMA NODOSUM LEPROSUM; ETHNICITY; GENDER; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; LEPROMATOUS LEPROSY; LEPROSY; MAJOR CLINICAL STUDY; MYCOBACTERIUM LEPRAE; NEPAL; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REVERSAL REACTION;

ADULT; DNA MUTATIONAL ANALYSIS; ERYTHEMA NODOSUM; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEPROSY; MALE; MANNOSE-BINDING LECTIN; NEPAL; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, CALCITRIOL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956610643     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.07.001     Document Type: Article

References (50)

1. Global leprosy situation. Wkly Epidemiol Rec 2009, 84:333-340. World Health Organization.
2. Britton W.J., Lockwood D.N. Leprosy. Lancet 2004, 363:1209-1219.
3. Scollard D.M., Adams L.B., Gillis T.P., Krahenbuhl J.L., Truman R.W., Williams D.L. The continuing challenges of leprosy. Clin Microbiol Rev 2006, 19:338-381.
4. Ranque B., Nguyen V., Vu H., Nguyen T., Nguyen N., Pham X., et al. Age is an important risk factor for onset and sequelae of reversal reactions in Vietnamese patients with leprosy. Clin Infect Dis 2007, 44:33-40.
5. Misch E.A., Macdonald M., Ranjit C., Sapkota B.R., Wells R.D., Siddiqui M.R., et al. Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl Trop Disord 2008, 2:e231.
6. Bochud P.-Y., Hawn T., Siddiqui M.R., Saunderson P., Britton S., Abraham I., et al. Toll-like. receptors 2 (TLR2) polymorphisms are associated with reversal reaction in leprosy. J Infect Dis 2008, 197:253-261.
7. Berrington W.R., Macdonald M., Khadge S., Sapkota B.R., Janer M., Hagge D.A., et al. Common polymorphisms in the NOD2 gene region are associated with leprosy and its reactive states. J Infect Dis 2010, 201:1422-1435.
8. Kahawita I.P., Lockwood D.N. Towards understanding the pathology of erythema nodosum leprosum. Trans R Soc Trop Med Hyg 2008, 102:329-337.
9. Berrington W.R., Hawn T.R. Mycobacterium tuberculosis, macrophages, and the innate immune response: Does common variation matter?. Immunol Rev 2007, 219:167-186.
10. Casanova J.-L., Abel L. Genetic dissection of immunity to mycobacteria: The human model. Annu Rev Immunol 2002, 20:581-620.
11. Fernando S.L., Britton W.J. Genetic susceptibility to mycobacterial disease in humans. Immunol Cell Biol 2006, 84:125-137.
12. Chakravartti M.R., Vogel F. A twin study on leprosy. Topics Hum Genet 1973, 1:1-23.
13. Mira M.T., Alcais A., Nguyen V.T., Moraes M.O., Di Flumeri C., Vu H.T., et al. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature 2004, 427:636-640.
14. Schurr E., Alcais A., de Leseleuc L., Abel L. Genetic predisposition to leprosy: A major gene reveals novel pathways of immunity to Mycobacterium leprae. Semin Immunol 2006, 18:404-410.
15. Siddiqui M.R., Meisner S., Tosh K., Balakrishnan K., Ghei S., Fisher S.E., et al. A major susceptibility locus for leprosy in India maps to chromosome 10p13. Nat Genet 2001, 27:439-441.
16. Zhang F.R., Huang W., Chen S.M., Sun L.D., Liu H., Li Y., et al. Genomewide Association study of leprosy. N Engl J Med 2009, 361:2609-2618.
17. Modlin R.L. The innate immune response in leprosy. Curr Opin Immunol 2010, 22:48-54.
18. Alcais A., Alter A., Antoni G., Orlova M., Van Thuc N., Singh M., et al. Stepwise replication identifies a low-producing lymphotoxin-[alpha] allele as a major risk factor for early-onset leprosy. Nat Genet 2007, 39:517-522.
19. Roy S., Frodsham A., Saha B., Hazra S.K., Mascie-Taylor C.G.N., Hill A.V.S. Association of vitamin D receptor genotype with leprosy type. J Infect Dis 1999, 179:187-191.
20. Franceschi D.S., Mazini P.S., Rudnick C.C., Sell A.M., Tsuneto L.T., Ribas M.L., et al. Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil. Int J Infect Dis 2008, 13:493-498.
21. Santos A.R., Suffys P.N., Vanderborght P.R., Moraes M.O., Vieira L.M.M., Cabello P.H., et al. Role of tumor necrosis factor-α and interleukin-10 promoter gene polymorphisms in leprosy. J Infect Dis 2002, 186:1687-1691.
22. Roy S., McGuire W., Mascie-Taylor C.G., Saha B., Hazra S.K., Hill A.V., Kwiatkowski D. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 1997, 176:530-532.
23. Shaw M.A., Donaldson I.J., Collins A., Peacock C.S., Lins-Lainson Z., Shaw J.J., et al. Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun 2001, 2:196-204.
24. de Messias-Reason I.J., Boldt A.B., Moraes B.A.C., Von R., Seeling Stahlke E., Dornelles L., et al. The association between mannan-binding lectin gene polymorphism and clinical leprosy: New insight into an old paradigm. J Infect Dis 2007, 196:1379-1385.
25. Alter A., de Leseleuc L., Van Thuc N., Thai V.H., Huong NT N.N., et al. Genetic and functional analysis of common MRC1 exon 7 polymorphisms in leprosy susceptibility. Hum Genet 2010, 127:337-348.
26. Knight J.C., Kwiatkowski D. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease. Proc Assoc Am Physicians 1999, 111:290-298.
27. Brinkman B.M., Zuijdeest D., Kaijzel E.L., Breedveld F.C., Verweij C.L. Relevance of the tumor necrosis factor alpha (TNF alpha) -308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 1995, 46:32-41.
28. Wilson A.G., Symons J.A., McDowell T.L., McDevitt H.O., Duff G.W. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997, 94:3195-3199.
29. Dommett R.M., Klein N., Turner M.W. Mannose-binding lectin in innate immunity: Past, present and future. Tissue Antigens 2006, 68:193-209.
30. Schlesinger L.S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J Immunol 1993, 150:2920-2930.
31. Sumiya M., Super M., Tabona P., Levinsky R.J., Arai T., Turner M.W., Summerfield J.A. Molecular basis of opsonic defect in immunodeficient children. Lancet 1991, 337:1569-1570.
32. Lipscombe R.J., Sumiya M., Hill A.V., Lau Y.L., Levinsky R.J., Summerfield J.A., Turner M.W. High frequencies in African and non-African populations of independent mutations in the mannose binding protein gene. Hum Mol Genet 1992, 1:709-715.
33. Madsen H.O., Garred P., Kurtzhals J.A., Lamm L.U., Ryder L.P., Thiel S., Svejgaard A. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics 1994, 40:37-44.
34. Mora J.R., Iwata M., von Andrian U.H. Vitamin effects on the immune system: Vitamins A and D take centre stage. Nat Rev Immunol 2008, 8:685-698.
35. Morrison N.A., Qi J.C., Tokita A., Kelly P.J., Crofts L., Nguyen T.V., et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994, 367:284-287.
36. van Etten E., Verlinden L., Giulietti A., Ramos-Lopez E., Branisteanu D.D., Ferreira G.B., et al. The vitamin D receptor gene FokI polymorphism: Functional impact on the immune system. Eur J Immunol 2007, 37:395-405.
37. Ridley D.S., Jopling W.H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 1966, 34:255-273.
38. Storm N., Darnhofer-Patel B., van den Boom D., Rodi C.P. MALDI-TOF mass spectrometry-based SNP genotyping. Methods Mol Biol 2003, 212:241-262.
39. Lockwood D.N., Vinayakumar S., Stanley J.N., McAdam K.P., Colston M.J. Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India. Int J Lepr Other Mycobact Dis 1993, 61:8-15.
40. Fitness J., Floyd S., Warndorff D.K., Sichali L., Mwaungulu L., Crampin A.C., et al. Large-scale candidate gene study of leprosy susceptibility in the Karonga district of Northern Malawi. Am J Trop Med Hyg 2004, 71:330-340.
41. Bayley J.P., Ottenhoff T.H., Verweij C.L. Is there a future for TNF promoter polymorphisms?. Genes Immun 2004, 5:315-329.
42. McGuire W., Hill A.V., Allsopp C.E., Greenwood B.M., Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994, 371:508-510.
43. Pacheco A.G., Cardoso C.C., Moraes M.O. +874T/A;IL10 -1082G/A and TNF -308G/A polymorphisms in association with tuberculosis susceptibility: A meta-analysis study. Hum Genet 2008, 123:477-484. IFNG.
44. Super M., Gillies S.D., Foley S., Sastry K., Schweinle J.E., Silverman V.J., Ezekowitz R.A. Distinct and overlapping functions of allelic forms of human mannose binding protein. Nat Genet 1992, 2:50-55.
45. Madsen H.O., Satz M.L., Hogh B., Svejgaard A., Garred P. Different molecular events result in low protein levels of mannan-binding lectin in populations from southeast Africa and South America. J Immunol 1998, 161:3169-3175.
46. Dornelles L.N., Pereira-Ferrari L., Messias-Reason I. Mannan-binding lectin plasma levels in leprosy: Deficiency confers protection against the lepromatous but not the tuberculoid forms. Clin Exp Immunol 2006, 145:463-468.
47. Goulart L.R., Ferreira F.R., Goulart I.M. Interaction of TaqI polymorphism at exon 9 of the vitamin D receptor gene with the negative lepromin response may favor the occurrence of leprosy. FEMS Immunol Med Microbiol 2006, 48:91-98.
48. Monot M., Honore N., Garnier T., Zidane N., Sherafi D., Paniz-Mondolfi A., et al. Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat Genet 2009, 41:1282-1289.
49. Hall B.G., Salipante S.J. Molecular epidemiology of Mycobacterium leprae as determined by structure-neighbor clustering. J Clin Microbiol 2010, 48:1997-2008.
50. Ingles S.A., Haile R.W., Henderson B.E., Kolonel L.N., Nakaichi G., Shi C.Y., et al. Strength of linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: Implications for association studies. Cancer Epidemiol Biomarkers Prev 1997, 6:93-98.